Salute e Benessere

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II…

Leuven, BELGIUM – May 15, 2025 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received transparency notifications as follows: Oxurion received a transparency notification on May 15, 2025, from Atlas Special…
Actusnews Wire
15/05/2025

BASTIDE : Continued strong organic growth in Q3 2024-2025 at +7.7%: Home…

Caissargues, May 15, 2025 In € millions 2023-2024 published 2023-2024* Adjusted 2024-2025 published Change First-quarter revenue 127.9 122.7 133.8 +9.1% Second-quarter revenue 137.0 130.8 141.4 +8.1% Third-quarter revenue 134.7 133.6 144.2 +7.9% Nine-month revenue 399.7 387.1 419.4 +8.4% *2023-2024 revenue restated for the scope effect related to…
Actusnews Wire
15/05/2025

Rznomics Enters Global Licensing Agreement with Eli Lilly for RNA-editing…

If Lilly exercises all available options under the agreement, the total deal value could reach more than $1.3 billion, as well as separate royalties on product sales. In line with the mutual understanding between the two companies, the upfront payment was not disclosed. If Lilly exercises all available options under the agreement, the total deal value could reach more than$1.3 billion, as well as separate royalties on product sales. In line with the mutual understanding between the two...
PR Newswire
15/05/2025

Sunscreen Market to Reach $38.6 Billion by 2035, Growing at a CAGR of 7.2% from…

For more comprehensive insights, download the FREE report sample: https://www.meticulousresearch.com/download-sample-report/cp_id=6173 Key Market Drivers and Trends The sunscreen market is experiencing significant growth due to increasing consumer awareness of skin health concerns and shifting preferences toward clean beauty and mineral-based formulations. Multi-functional sun protection products that combine SPF with skincare benefits are gaining substantial traction, while...
PR Newswire
15/05/2025

Surface Disinfectant Market Share to Hit 7.2% CAGR, Globally, by 2030- Exclusive…

Shift Toward Alcohol-free and Biobased Surface Disinfectants: The surface disinfectant market has experienced a major transformation as alcohol-free and botanical-based products gain popularity. Alcohol-based disinfectants like isopropyl alcohol took precedence during the height of the pandemic because of their quick germ-killing abilities yet skin irritation, toxicity and flammability issues prompted consumers and institutions to search for safer substitutes. Natural ingredients like tea tree…
PR Newswire
15/05/2025

Fotona® Appoints Jeff Duchemin as Group President and CEO

Duchemin brings decades of leadership experience in the global medical technology sector, having held senior roles in both U.S. and international markets. Most recently, he served in executive roles in the Interventional Surgery and Integrated Diagnostic Solutions business at Becton Dickinson along with being the former President and CEO of Harvard Biosciences. His expertise in driving revenue growth—both organically and through strategic acquisitions—will play a critical role in advancing…
PR Newswire
15/05/2025

IMU Biosciences Adopts Curiox's Pluto for Large-Scale UK Immune Profiling…

Leading AI-Powered Immune Profiling Company IMU to Adopt Pluto Workstation for Large-Scale Immune Phenotyping Project Based on UK Patient Big Data Dr. Nori Ueno, Vice President of Sales at Curiox, commented:, “IMU's decision to adopt Pluto is a strong validation of the commercial and technological value of our Pluto Wash platform. As demand for AI/ML-driven analysis and automation continues to expand across life sciences, Pluto will play a central role in accelerating precision research and...
Nasdaq GlobeNewswire
15/05/2025

Abzena Announces Establishment of Scientific Advisory Board to Support…

Joe Principe, CCO of Abzena, said, "We are honored to welcome these distinguished individuals to our Scientific Advisory Board. These founding members are recognized leaders in our industry, bringing a wealth of expertise that will help guide us as we continue through this significant phase of our growth. We look forward to their contributions and the positive impact that they will have on our organization." Joe Principe, CCO of Abzena, said, "We are honored to welcome these…
PR Newswire
15/05/2025

Vendor Neutral Archive (VNA) & PACS Market worth US$7.92 billion by 2030 with…

Browse in-depth TOC on "Vendor Neutral Archive (VNA) & PACS Market" Browse in-depth TOC on "Vendor Neutral Archive (VNA) & PACS Market" 310 - Tables 47 - Figures 350 - Pages By Based on product type,the VNA & PACS market is categorized into VNA and PACS. In 2024, the VNA segment accounted for a larger market share due to its ability to decouple medical imaging data from proprietary departmental systems. This methodology facilitates centralized data storage,...
PR Newswire
15/05/2025

In Vitro Diagnostics Market Share worth $150.13 billion, Globally by 2030 -…

The key players in the In Vitro Diagnostics Market are, Abbott Laboratories (USA), Bio-Rad Laboratories, Inc. (USA), Siemens Healthineers AG (Germany), bioMérieux SA (France), Becton, Dickinson and Company (BD) (USA), QIAGEN N.V. (Netherlands), QuidelOrtho Corporation (USA), F. Hoffmann-La Roche Ltd (Switzerland), Danaher Corporation (USA), Quest Diagnostics Incorporated (USA), and Agilent Technologies, Inc. (USA). The key players in the In Vitro Diagnostics Market are, Abbott Laboratories (...
PR Newswire
15/05/2025

Enteral Feeding Devices Market worth US$3,994.2 million by 2030 with 6.0% CAGR |…

Browse in-depth TOC on "Enteral Feeding Devices Market" Browse in-depth TOC on "Enteral Feeding Devices Market" 400 - Tables 280 - Figures 420 - Pages By Based on product,the enteral feeding devices market is segmented into enteral feeding tubes [nasal feeding tubes (nasogastric feeding tubes, nasojejunal feeding tubes, nasoduodenal feeding tubes), oral feeding tubes (orogastric tubes, oroenteric tubes), gastric/gastrostomy tubes, jejunostomy tubes, and...
PR Newswire
15/05/2025

CIT Srl Charts a Visionary Path in Supply Chain Digitalization with TraceLink's…

Developed on OPUS, the Orchestration Platform for Universal Solutions, MINT will empower CIT Srl to achieve higher levels of collaboration and operational efficiency, enrich inventory visibility and forecasting with real-time data, and deliver the revenue predictability that fuels sustainable growth and corporate profitability. With MINT, CIT Srl will unlock a range of strategic benefits that directly support its business success and market expansion goals: Developed on OPUS, the…
PR Newswire
15/05/2025

Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross…

Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, today reported financial results for the first quarter ended March 31, 2025. First Quarter 2025 Financial HighlightsIncome Statement Cosmos Health delivered...
Nasdaq GlobeNewswire
15/05/2025

Alamar Biosciences Expands NULISAseq™ CNS Disease Panel 120 with Groundbreaking…

Phosphorylated tau has emerged as a critical biomarker for early detection and monitoring of Alzheimer's disease and other tauopathies. The new additions to the CNS Disease 120 Panel are specifically designed to detect brain-derived forms of pTau, overcoming the limitations of current assays that cannot distinguish between peripheral and central tau species. This allows for the simultaneous measurement of two suites of multiple pTaus and tTau species, one specific for brain-derived and one…
PR Newswire
15/05/2025

Resmed Champions Sleep Health as The Official Sleep Partner of The Qatar Airways…

SAN DIEGO and LONDON and DUBLIN and SYDNEY, May15, 2025(GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, has been named the Official Sleep Partner of the Qatar Airways British & Irish Lions Tour to Australia.The Tour brings rugby fans' dreams to life over a six-week period. For the first time in 12 years, The Lions squad, alongside an estimated 40,000 fans, will battle it out with the...
Nasdaq GlobeNewswire
15/05/2025

New Novartis data at ASCO and EHA showcase momentum of pioneering portfolio with…

NATALEE subanalysis evaluates Kisqali in pre-menopausal early breast cancer patients, amid rising diagnosis rates in younger patients Pluvicto analysis and Scemblix ASC4START primary endpoint results provide insights into use in earlier settingsFabhalta APPULSE-PNH full results build on Phase III program, reporting new data from expanded PNH population in adults switching from anti-C5Ianalumab Phase II data in immune thrombocytopenia and longer-term pelabresib Phase III...
Nasdaq GlobeNewswire
15/05/2025

Medicines for Poland: Europe Faces a Critical Choice on Medicines and Market…

Member States are nearing the end of discussions on EU pharmaceutical reform to ensure affordable medicines and support EU manufacturing in Europe. This will enhance the Union's strategic resilience and autonomy, promote economic growth, and strengthen the sustainability of national healthcare systems. Europe is facing shortages of medicines, with dependence on the supply of key pharmaceutical ingredients from Asia reaching 80%. Restoring essential medicine production is vital to Europe's...
Nasdaq GlobeNewswire
15/05/2025

IM Cannabis Reports First Quarter Financial Results

IMC also announces the intention to complete a non-brokered private placement of secured debentures. IMC also announces the intention to complete a non-brokered private placement of secured debentures. Q1 2025 Financial Highlights Management Commentary "Q1 2025 is a clear inflection point for IMC," said Oren Shuster, Chief Executive Officer of IMC. " Achieving net profitability and an 87% improvement in gross margin year-over-year demonstrates the strength of the strategic...
PR Newswire
15/05/2025

Journal of Clinical Nuclear Medicine Publishes Results of Tiziana's Nasal…

TLSA ) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, today announced the publication of a new study in the Journal of 'Clinical Nuclear Medicine' demonstrating that intranasal administration of foralumab significantly dampened microglial activation in a 78-year old patient with moderate Alzheimer's disease (AD) treated as part of a...
Nasdaq GlobeNewswire
15/05/2025

Intalight™ Receives CE Mark for Its Progressive DREAM OCT™ Swept Source Imaging

"Intalight is incredibly proud to receive CE mark approval in Europe for our DREAM OCT," said Intalight chairman and Founder, Shawn Peng. "This achievement allows us to provide ophthalmologists in Europe with state-of-the-art technology that delivers improved results for their patients." "Intalight is incredibly proud to receive CE mark approval inEuropefor our DREAM OCT," said Intalight chairman and Founder,Shawn Peng. "This achievement allows us to provide…
PR Newswire
15/05/2025

Curaleaf International Launches a Range of Medical Cannabis Products in…

Over the coming months, patients and healthcare professionals in Australia can look forward to a broader portfolio and further innovative solutions offered by Curaleaf, including precision-dosed inhalation formats and popular strains already widely prescribed across the UK, Germany, and other key European markets. Over the coming months, patients and healthcare professionals inAustraliacan look forward to a broader portfolio and further innovative solutions offered by Curaleaf, including...
PR Newswire
15/05/2025

NeutroFlow: Leading European Medical Consortium Awarded €2.5 Million Grant from…

The principal investigators representing each consortium partner are: Prof. Petros Christopoulos, Dr. Stefanie Zschäbitz and Dr. Sebastian Dieter from Heidelberg University, Prof. Francesco Bertolini and Dr. Patrizia Mancuso from the European Institute of Oncology (IEO), Dr. Luis de la Cruz, Dr. David Vicente-Baz, and Dr. Alberto Morenofrom Virgen Macarena University Hospital, and Dr. Michal Harel from OncoHost. These distinguished leaders bring unparalleled expertise across translational…
PR Newswire
15/05/2025

Viva Biotech Launches the AI-Driven Drug Discovery Platform, Transforming New…

SBDD Platform Powered by AI and Discovery Magic SBDD Platform Powered by AI and Discovery Magic As a one-stop drug discovery solution provider, Viva Biotech embraced atomic-level perspective. Dr. Qian emphasized that Viva has over 15 years of experience in structure-based drug discovery (SBDD), supported by established high-throughput, affinity-based screening platforms, comprehensive biophysical and biochemical assays, and dedicated medicinal chemistry and biologics teams. Viva's...
PR Newswire
15/05/2025

Carrick Therapeutics Announces New Clinical Data Supporting Biomarker-driven…

Two independent Phase 2 trials demonstrate extended progression-free survival in patients without TP53 mutations or without liver metastasesResults presented at 2025 ESMO Breast Cancer Annual Congress BOSTON, May15, 2025(GLOBE NEWSWIRE) -- Carrick Therapeutics Inc., an oncology-focused biopharmaceutical company discovering and developing highly differentiated therapies, today announced results from a new analysis of two Phase 2 clinical trials of samuraciclib, a novel...
Nasdaq GlobeNewswire
15/05/2025
Altri  Comunicati